Navigation Links
World Biochips Market to Reach $3.4 billion by 2012, According to New Report by Global Industry Analysts, Inc.
Date:10/29/2008

Global biochips market is forecast to experience robust growth and is on course to reach $3.4 billion by 2012. Aging population, third party reimbursement, and a growing number of individuals suffering from common chronic diseases represent the key market drivers.

San Jose, CA (PRWEB) October 29, 2008 -- Significant dimensions of the vast parallel studies afforded by biochips have created a holistic means of viewing biological systems. In addition to the combination of various sciences, space, time and expense are all key factors in the future development of biochips. Modern day chips can contain a human genome comprising of 30,000 to 100,000 genes.

Global biochips market is forecast to register stupendous growth and reach US$3.4 billion by 2012, as stated by Global Industry Analysts, Inc. United States represents the largest market with sales estimated to exceed US$996 million in 2008. Increasing at a robust CAGR of 29% over 2000-2010 period, Europe is the fastest growing biochips market, followed by the US. Within Europe, Germany represents the single-largest market, expected to account for an estimated 37.5% share in 2008. In terms of segments, World DNA chips market dominates the biochips industry with revenues forecast to exceed US$1.44 billion by 2012.

Protein chips market represents the fastest growing segment with an astounding CAGR of over 58% for the 2000-2010 period. Protein biochip industry is expected to undergo major changes due to the regard for protein biomarkers, and the tailback in lead optimization and target corroboration.

The biochip industry is in the early stages of growth and hence, not only promises potential but also is susceptible to vagaries of market forces. Competition, patent disputes, knowledge constraints (in terms of skilled employees, technical know-how) and financial strength might be a few impediments for firms engaged in this industry. A promising market arises from three factors - an aging population, third party reimbursement and a growing number of individuals suffering from common chronic diseases. Gene expression profiling will continue to be the leading application of biochips. Biochips would certainly evolve in terms of physical and technical characteristics. Following the focus on miniaturization of assays, they would turn smaller and more powerful with each generation.

The biochip industry is characterized by both intense rivalry and an equally well-developed web of alliances. There are numerous smaller companies and hence it is no surprise that the bigger companies are able to buy their way into the market. Companies currently compete within narrow confines of genomic demand and technological prowess. Leading players operating in the biochips market include Affymetrix, Applied Biosystems Group, Biomerieux, Bio-Rad Laboratories, Inc., Caliper Life Sciences, Inc., Cepheid Inc., GE Healthcare Ltd., Takara Bio, Inc., and Zyomyx.

The report titled "Biochips: A Global Strategic Business Report" published by Global Industry Analysts, Inc., captures latest market trends, issues and technology advancements of the US, Canada, Japan, Europe (France, Germany, United Kingdom, and Rest of Europe), and Rest of World. The report further provides a brief insight into the competitive scenario, product and technology trends, new product innovations and developments and recent strategic corporate developments.

For more details about this research report, please visit http://www.strategyr.com/Biochips_Market_Report.asp

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of over 60,000 smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Email press @ strategyR.com
Web Site http://www.StrategyR.com/

###

Read the full story at http://www.prweb.com/releases/biochips_DNA_chips/protein_lab_microarrays/prweb1536884.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. WorldHeart Appoints David Pellone Chief Financial Officer
2. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
3. Kingfisher Healthcare (KFH) Achieves World Class Quality Platform
4. Data from Patient Subsets of e-HEALING, a Worldwide Registry, Support Use of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM) as Alternative to Drug- Eluting Stents
5. National Association for Sport and Physical Education Partners with S&S Worldwide to Help Improve Childrens Fitness
6. Hundreds of RNs from Across U.S. and World to Join California Nurses Association/NNOC National Convention
7. Neusoft Becomes First Global Growth Company Partner of World Economic Forum
8. Depression May Be Worlds Most Disabling Disease
9. Concentra Opens On-Site Medical Unit at World Trade Center Site
10. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
11. Womens World Banking Welcomes New Network Member From Tunisia
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
World Biochips Market to Reach $3.4 billion by 2012, According to New Report by Global Industry Analysts, Inc.
(Date:5/4/2016)... ... 04, 2016 , ... Trinity Health today launched its inaugural ... aimed at improving care and reducing readmission rates for patients who are dually ... Health is to drive innovation that transforms our ministry and our industry to ...
(Date:5/4/2016)... SCOTTSDALE, AZ (PRWEB) , ... May 04, 2016 ... ... 2016 Annual Technology & Business Conference. The conference opened on Tuesday with Frank ... panel discussion on NCPDP’s PDMP Solution provided a deep dive on NCPDP’s model ...
(Date:5/4/2016)... ... ... Level 10 Head Over Heels Athletic Arts’ gymnast Alessandra Brovedani -- who goes ... fall of 2019. , After a handful of college visits, the Berkeley High ... her connection with the coaching staff and the excitement surrounding Wildcat Athletics. , “What ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... therapy products, announced today the introduction of the innovative newly improved Iso-Hip Wrap. ... hip replacement patients. The plush design enhances comfort and enables the patient to ...
(Date:5/4/2016)... , ... May 04, 2016 , ... Nike Rugby Camp's ... rugby in San Diego. Willis, founder of Elite Rugby Camps and current Nike Camp ... players every year since 2009. , “I’m excited for our eighth summer here ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... , May 3, 2016   Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that it is ... a video of two patients who tell their personal story and encourage those at risk ... Meet Jacque: Hepatitis C ... ... Diplomat Specialty Pharmacy (PRNewsFoto/Diplomat Pharmacy, Inc.) ...
(Date:5/3/2016)... May 3, 2016  Forté Elements, LLC (Forté) is excited to announce the launch ... address the nutritional needs of recovery for a variety of clinical conditions. Founded in ... Photo - http://photos.prnewswire.com/prnh/20160502/362548 Logo -  http://photos.prnewswire.com/prnh/20160502/362547LOGO ... ... ...
(Date:5/2/2016)...  Deerfield announced today it led the $44.5 ... Graybug Vision is an early stage pharmaceutical company ... for ocular diseases including wet age-related macular degeneration ... developed at Johns Hopkins University and has been ... Graybug Vision is developing ophthalmology products enabling ...
Breaking Medicine Technology: